Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for InMed Pharmaceuticals Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
AC
ADAR1 Capital Management, LLC
|
800.0K | 14.63% | NEW | Q2 '26 | 0.1% | |
|
Shares held by quarter
Peak holding800.0K (Q2'26)
Change over 8 quarters+800.0K
Share of the company14.630%
|
||||||
|
VC
Vivo Capital, LLC
|
798.4K | 14.60% | NEW | Q2 '26 | 0.1% | |
|
Shares held by quarter
Peak holding798.4K (Q2'26)
Change over 8 quarters+798.4K
Share of the company14.600%
|
||||||
20 more super investors behind a free account
See every manager holding InMed Pharmaceuticals Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
BA
Blackstone Alternative Investment Funds
|
$10.1K | 6.5K | 0.12% | 0.00% | June 30, 2026 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FF
Fairmount Funds Management LLC
5%+ holder
13D · 20.0%
|
10.6M | 192.99% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
FH
Fairmount Healthcare Fund II L.P.
5%+ holder
13D · 20.0%
|
10.6M | 192.99% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
8 more holders behind a free account
See every insider and 5%+ holder of InMed Pharmaceuticals Inc..
Sign up freeLoading...